Sitagliptin and saxagliptin are both DPP-4 inhibitors used to manage type 2 diabetes. Sitagliptin generally shows fewer allergic reactions and less risk of heart failure compared to saxagliptin. Efficacy is similar, but some patients prefer sitagliptin due to its once-daily dosing.